Sam Lemmer Counseling And Ecotherapy | |
19477 47th St Bloomingdale MI 49026-9787 | |
(312) 961-7609 | |
Not Available |
Full Name | Sam Lemmer Counseling And Ecotherapy |
---|---|
Speciality | Counselor - Professional |
Location | 19477 47th St, Bloomingdale, Michigan |
Authorized Official Name and Position | Samantha Lemmer (OWNER) |
Authorized Official Contact | 3129617609 |
Accepts Medicare Insurance | This clinic does not participate in Medicare Program. |
Mailing Address | Practice Location Address |
---|---|
Sam Lemmer Counseling And Ecotherapy 19477 47th St Bloomingdale MI 49026-9787 Ph: (312) 961-7609 | Sam Lemmer Counseling And Ecotherapy 19477 47th St Bloomingdale MI 49026-9787 Ph: (312) 961-7609 |
NPI Number | 1407595473 |
---|---|
Provider Enumeration Date | 05/29/2022 |
Last Update Date | 05/29/2022 |
Certification Date | 05/29/2022 |
Identifier | Type | State | Issuer |
---|---|---|---|
1407595473 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
101YP2500X | Counselor - Professional | (* (Not Available)) | Primary |
News Archive
Nymox Pharmaceutical Corporation announced today that the Company is nearing completion of a new multi-center U.S. long-term follow-up study of NX-1207, its investigational drug for the treatment of benign prostatic hyperplasia (BPH). Nymox expects to report final results and statistical analysis for the study in the next 1-2 weeks. The new study concerns assessment of the 48-60 month efficacy and benefits of a single treatment of NX-1207.
A new review outlines potential pharmaceutical, dietary, surgical, and other approaches to reducing the risk of breast cancer among women in the United States, and examines the evidence for specific recommendations.
A Centers for Medicare & Medicaid Services official, testifying before the House Ways and Means Committee, said it would take six more months to figure out this cost and that he could not yet provide a timetable for removing Social Security numbers from Medicare cards.
Scientists at The University of Manchester have developed a new technique which uses electricity to engineer human tissue.
Bausch & Lomb, the global eye health company, today announced it has acquired the commercial assets of Tubilux Pharma S.p.A.
› Verified 6 days ago